5&2 Studios, Inc.

2023 Q2 Form 10-Q Financial Statement

#000141057823001938 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $108.9M $9.902M
Short-Term Investments
Other Short-Term Assets $1.733M
YoY Change
Inventory $7.978M
Prepaid Expenses $2.812M
Receivables $6.058M
Other Receivables
Total Short-Term Assets $127.5M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $31.60M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.328M
YoY Change
Total Long-Term Assets $83.74M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $127.5M
Total Long-Term Assets $83.74M
Total Assets $211.3M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.252M
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue $896.0K
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $2.119M
YoY Change
Total Short-Term Liabilities $11.57M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $143.0M
YoY Change
Other Long-Term Liabilities $3.069M
YoY Change
Total Long-Term Liabilities $146.1M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $11.57M
Total Long-Term Liabilities $146.1M
Total Liabilities $165.7M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $27.68M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $211.3M
YoY Change

Cashflow Statement

Concept 2023 Q2 2022 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001733443
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
dei Entity Registrant Name
EntityRegistrantName
Chosen, Inc.
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Amendment Flag
AmendmentFlag
false
dei Security Exchange Name
SecurityExchangeName
NONE
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4341000
us-gaap Revenue Related Party Type Extensible Enumeration
RevenueRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2 us-gaap Revenue Related Party Type Extensible Enumeration
RevenueRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
us-gaap Revenue Related Party Type Extensible Enumeration
RevenueRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q2 us-gaap Revenue Related Party Type Extensible Enumeration
RevenueRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2 us-gaap Other Liability Related Party Type Extensible Enumeration
OtherLiabilityRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Liability Related Party Type Extensible Enumeration
OtherLiabilityRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55029
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3246222
dei Entity Address Address Line1
EntityAddressAddressLine1
4 S 2600 W, Suite 5
dei Entity Address City Or Town
EntityAddressCityOrTown
Hurricane,
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84737
dei City Area Code
CityAreaCode
435
dei Local Phone Number
LocalPhoneNumber
767-1338
dei Security12g Title
Security12gTitle
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108942000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124790000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
158000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6058000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8983000
CY2023Q2 us-gaap Inventory Net
InventoryNet
7978000
CY2022Q4 us-gaap Inventory Net
InventoryNet
6110000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2812000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
754000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1733000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
864000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
127523000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
141501000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31601000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34426000
CY2023Q2 us-gaap Film Costs
FilmCosts
50808000
CY2022Q4 us-gaap Film Costs
FilmCosts
33276000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1328000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1042000
CY2023Q2 us-gaap Assets
Assets
211260000
CY2022Q4 us-gaap Assets
Assets
210245000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2252000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5549000
CY2023Q2 none Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
6791000
CY2022Q4 none Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
12827000
CY2023Q2 none Long Term Debt And Lease Liabilities.Current
LongTermDebtAndLeaseLiabilities.Current
2527000
CY2022Q4 none Long Term Debt And Lease Liabilities.Current
LongTermDebtAndLeaseLiabilities.Current
2463000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11570000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20839000
CY2023Q2 none Long Term Debt And Lease Liabilities.Noncurrent
LongTermDebtAndLeaseLiabilities.Noncurrent
142860000
CY2022Q4 none Long Term Debt And Lease Liabilities.Noncurrent
LongTermDebtAndLeaseLiabilities.Noncurrent
143377000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3069000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2571000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8244000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5104000
CY2023Q2 us-gaap Liabilities
Liabilities
165743000
CY2022Q4 us-gaap Liabilities
Liabilities
171891000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
none Preferred Stock Dividend Preference Percent
PreferredStockDividendPreferencePercent
1.20
CY2022 none Preferred Stock Dividend Preference Percent
PreferredStockDividendPreferencePercent
1.20
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4341000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
5000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10237000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10237000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27678000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18004000
CY2023Q2 us-gaap Minority Interest
MinorityInterest
7589000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
10100000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
45517000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38354000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
211260000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
210245000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26735000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2650000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51448000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7933000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
5519000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
262000
us-gaap Cost Of Revenue
CostOfRevenue
11429000
us-gaap Cost Of Revenue
CostOfRevenue
649000
CY2023Q2 us-gaap Advertising Expense
AdvertisingExpense
2559000
CY2022Q2 us-gaap Advertising Expense
AdvertisingExpense
68000
us-gaap Advertising Expense
AdvertisingExpense
4186000
us-gaap Advertising Expense
AdvertisingExpense
326000
CY2023Q2 us-gaap Film Monetized On Its Own And Film Monetized In Film Group Amortization Expense
FilmMonetizedOnItsOwnAndFilmMonetizedInFilmGroupAmortizationExpense
4688000
CY2022Q2 us-gaap Film Monetized On Its Own And Film Monetized In Film Group Amortization Expense
FilmMonetizedOnItsOwnAndFilmMonetizedInFilmGroupAmortizationExpense
535000
us-gaap Film Monetized On Its Own And Film Monetized In Film Group Amortization Expense
FilmMonetizedOnItsOwnAndFilmMonetizedInFilmGroupAmortizationExpense
8676000
us-gaap Film Monetized On Its Own And Film Monetized In Film Group Amortization Expense
FilmMonetizedOnItsOwnAndFilmMonetizedInFilmGroupAmortizationExpense
1389000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2232000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
65000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4377000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
96000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6888000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2507000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13372000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4215000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4849000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-787000
us-gaap Operating Income Loss
OperatingIncomeLoss
9408000
us-gaap Operating Income Loss
OperatingIncomeLoss
1258000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
210000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
765000
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
21000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5064000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-787000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10194000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1258000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1527000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3141000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
335000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
3537000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-595000
us-gaap Profit Loss
ProfitLoss
7053000
us-gaap Profit Loss
ProfitLoss
923000
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1353000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-63000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2621000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-92000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
4890000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-532000
us-gaap Net Income Loss
NetIncomeLoss
9674000
us-gaap Net Income Loss
NetIncomeLoss
1015000
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1015000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4890000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-532000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9674000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12545
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12545
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7190
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7190
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12545
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12545
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7190
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7190
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41980000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
3537000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
45517000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38354000
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
110000
us-gaap Profit Loss
ProfitLoss
7053000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
45517000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49455000
CY2022Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
594000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-595000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49454000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44379000
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
4152000
us-gaap Profit Loss
ProfitLoss
923000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49454000
us-gaap Profit Loss
ProfitLoss
7053000
us-gaap Profit Loss
ProfitLoss
923000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4377000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
96000
us-gaap Film Monetized On Its Own And Film Monetized In Film Group Amortization Expense
FilmMonetizedOnItsOwnAndFilmMonetizedInFilmGroupAmortizationExpense
8676000
us-gaap Film Monetized On Its Own And Film Monetized In Film Group Amortization Expense
FilmMonetizedOnItsOwnAndFilmMonetizedInFilmGroupAmortizationExpense
1389000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3141000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
613000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
67000
none Non Cash Lease Expense In Operating Activities
NonCashLeaseExpenseInOperatingActivities
-33000
none Non Cash Lease Expense In Operating Activities
NonCashLeaseExpenseInOperatingActivities
-60000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-158000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2937000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12949000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1868000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2927000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1286000
us-gaap Increase Decrease In Film Costs1
IncreaseDecreaseInFilmCosts1
26437000
us-gaap Increase Decrease In Film Costs1
IncreaseDecreaseInFilmCosts1
13265000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3347000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1035000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4381000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-184000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
498000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3574000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2832000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1488000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13094000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
86000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1488000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13008000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
110000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
4152000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
9000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7000
us-gaap Repayments Of Debt
RepaymentsOfDebt
470000
us-gaap Payments Of Dividends
PaymentsOfDividends
10417000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10786000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4145000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15848000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6030000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
124790000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15932000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108942000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9902000
us-gaap Interest Paid Net
InterestPaidNet
731000
us-gaap Interest Paid Net
InterestPaidNet
1000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
158000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company maintains its cash in bank deposit accounts which, at times, exceed federally insured limits. As of June 30, 2023 and December 31, 2022, the bank balance exceeded the federally insured limit by $23,580 thousand and $124,293 thousand, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A major customer is considered to be one that comprises more than 10% of the Company’s accounts receivable or annual revenues. During the three months and six months ended June 30, 2023, 86.7% and 78.3%, respectively, of the Company’s revenues were with Angel Studios, Inc. (“Angel Studios”) and the Come and See Foundation, Inc. (“CAS”). During the three months and six months ended June 30, 2022, 95.2% and 93.5%, respectively, of the Company's revenues were with Angel Studios. As of June 30, 2023 and December 31, 2022, 82.5% and 92.0%, respectively, of the Company’s accounts receivable was due from Angel Studios and CAS.</p>
CY2023Q2 none Bank Balance Exceeds Fdic Insured Amount
BankBalanceExceedsFdicInsuredAmount
23580000
CY2022Q4 none Bank Balance Exceeds Fdic Insured Amount
BankBalanceExceedsFdicInsuredAmount
124293000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26735000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2650000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51448000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7933000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
896000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
165000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1929000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2571000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2825000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2736000
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
165000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
985000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
985000
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6993000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5125000
CY2023Q2 us-gaap Inventory Net
InventoryNet
7978000
CY2022Q4 us-gaap Inventory Net
InventoryNet
6110000
CY2022Q2 none Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
317000
none Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
814000
none Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
317000
CY2023Q2 us-gaap Lease Cost
LeaseCost
814000
CY2022Q2 us-gaap Lease Cost
LeaseCost
353000
us-gaap Lease Cost
LeaseCost
1187000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39187000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
37649000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7586000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3223000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31601000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34426000
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2022Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2023Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2023Q2 none Film Capitalized Cost Released And Completed
FilmCapitalizedCostReleasedAndCompleted
47612000
CY2022Q4 none Film Capitalized Cost Released And Completed
FilmCapitalizedCostReleasedAndCompleted
47362000
CY2023Q2 none Film Capitalized Cost Not Released In Production
FilmCapitalizedCostNotReleasedInProduction
28589000
CY2022Q4 none Film Capitalized Cost Not Released In Production
FilmCapitalizedCostNotReleasedInProduction
2250000
CY2023Q2 none Film Capitalized Cost In Development And Preproduction
FilmCapitalizedCostInDevelopmentAndPreproduction
378000
CY2022Q4 none Film Capitalized Cost In Development And Preproduction
FilmCapitalizedCostInDevelopmentAndPreproduction
759000
CY2023Q2 none Film Capitalized Cost Gross
FilmCapitalizedCostGross
76579000
CY2022Q4 none Film Capitalized Cost Gross
FilmCapitalizedCostGross
50371000
CY2023Q2 none Film Capitalized Cost Accumulated Amortization
FilmCapitalizedCostAccumulatedAmortization
25771000
CY2022Q4 none Film Capitalized Cost Accumulated Amortization
FilmCapitalizedCostAccumulatedAmortization
17095000
CY2023Q2 us-gaap Film Costs
FilmCosts
50808000
CY2022Q4 us-gaap Film Costs
FilmCosts
33276000
CY2023Q2 us-gaap Film Monetized On Its Own And Film Monetized In Film Group Amortization Expense
FilmMonetizedOnItsOwnAndFilmMonetizedInFilmGroupAmortizationExpense
4688000
CY2022Q2 us-gaap Film Monetized On Its Own And Film Monetized In Film Group Amortization Expense
FilmMonetizedOnItsOwnAndFilmMonetizedInFilmGroupAmortizationExpense
535000
us-gaap Film Monetized On Its Own And Film Monetized In Film Group Amortization Expense
FilmMonetizedOnItsOwnAndFilmMonetizedInFilmGroupAmortizationExpense
8676000
us-gaap Film Monetized On Its Own And Film Monetized In Film Group Amortization Expense
FilmMonetizedOnItsOwnAndFilmMonetizedInFilmGroupAmortizationExpense
1389000
us-gaap Lease Cost
LeaseCost
384000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
2000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
2000
us-gaap Operating Lease Payments
OperatingLeasePayments
330000
CY2023Q2 none Film Costs Expected Amortization Remainder Of Fiscal Year
FilmCostsExpectedAmortizationRemainderOfFiscalYear
9755000
CY2023Q2 none Film Costs Expected Amortization Year One
FilmCostsExpectedAmortizationYearOne
5231000
CY2023Q2 none Film Costs Expected Amortization Year Two
FilmCostsExpectedAmortizationYearTwo
4948000
CY2023Q2 none Film Costs Expected Amortization Year Three
FilmCostsExpectedAmortizationYearThree
1567000
CY2023Q2 none Film Costs Expected Amortization Year Four
FilmCostsExpectedAmortizationYearFour
340000
CY2023Q2 none Film Costs Expected Amortization
FilmCostsExpectedAmortization
21841000
none Lessee Lease Number Of Renewal Options
LesseeLeaseNumberOfRenewalOptions
4
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1043000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
889000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
76000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
86000
CY2023Q2 none Right Of Use Asset
RightOfUseAsset
1119000
CY2022Q4 none Right Of Use Asset
RightOfUseAsset
975000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
389000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
533000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
19000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
19000
CY2023Q2 none Lease Liabilities Current
LeaseLiabilitiesCurrent
408000
CY2022Q4 none Lease Liabilities Current
LeaseLiabilitiesCurrent
552000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
440000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
338000
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
59000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
68000
CY2023Q2 none Lease Liabilities Non Current
LeaseLiabilitiesNonCurrent
499000
CY2022Q4 none Lease Liabilities Non Current
LeaseLiabilitiesNonCurrent
406000
CY2023Q2 none Lease Liabilities
LeaseLiabilities
907000
CY2022Q4 none Lease Liabilities
LeaseLiabilities
958000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
5000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
10000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3000
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
185000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
32000
us-gaap Operating Lease Cost
OperatingLeaseCost
361000
us-gaap Operating Lease Cost
OperatingLeaseCost
63000
CY2023Q2 none Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
623000
us-gaap Operating Lease Payments
OperatingLeasePayments
3000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
293000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
561000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
97000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M21D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M10D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M29D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M29D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0606
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0635
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0426
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0426
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
308000
CY2023Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
11000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
220000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
22000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
211000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
22000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
151000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
22000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
7000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
890000
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
84000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
61000
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
6000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
829000
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
78000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1729000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
273000
CY2023Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1384000
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1383000
CY2023Q2 none Accrued Contractor Payments Current
AccruedContractorPaymentsCurrent
1005000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
896000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
165000
CY2023Q2 none Accrued Inventory Purchases Current
AccruedInventoryPurchasesCurrent
637000
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
10417000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1140000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
589000
CY2023Q2 none Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
6791000
CY2022Q4 none Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
12827000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
142981000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
143659000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2119000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1911000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
145100000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
145570000
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
620000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
688000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1527000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3141000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
335000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.30
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.24
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.31
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.27
CY2023Q2 none Increase In Effective Tax Rate
IncreaseInEffectiveTaxRate
0.06
CY2023Q2 none Effective Income Tax Impact From Net Income Loss Attributable To Non Controlling Interest
EffectiveIncomeTaxImpactFromNetIncomeLossAttributableToNonControllingInterest
-1290000
none Increase In Effective Tax Rate
IncreaseInEffectiveTaxRate
0.04
none Effective Income Tax Impact From Net Income Loss Attributable To Non Controlling Interest
EffectiveIncomeTaxImpactFromNetIncomeLossAttributableToNonControllingInterest
-2529000
CY2023Q2 us-gaap Revenues
Revenues
0
CY2022Q2 us-gaap Revenues
Revenues
2523000
us-gaap Revenues
Revenues
0
us-gaap Revenues
Revenues
7417000
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
0
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
0

Files In Submission

Name View Source Status
0001410578-23-001938-index-headers.html Edgar Link pending
0001410578-23-001938-index.html Edgar Link pending
0001410578-23-001938.txt Edgar Link pending
0001410578-23-001938-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20230630.xsd Edgar Link pending
tmb-20230630x10q.htm Edgar Link pending
tmb-20230630xex31d1.htm Edgar Link pending
tmb-20230630xex31d2.htm Edgar Link pending
tmb-20230630xex32d1.htm Edgar Link pending
tmb-20230630xex32d2.htm Edgar Link pending
tmb-20230630_cal.xml Edgar Link unprocessable
tmb-20230630x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
tmb-20230630_lab.xml Edgar Link unprocessable
tmb-20230630_def.xml Edgar Link unprocessable
tmb-20230630_pre.xml Edgar Link unprocessable